ImmiPrint® TB Triage Test
Active Tuberculosis (Rule-Out)
Clinically ValidatedActive
Key Facts
About ProteinLogic
Founded in 2004 and based in Cambridge, UK, ProteinLogic is a private diagnostics company pioneering a novel approach to disease detection and monitoring. Its core ImmiPrint® platform analyzes patterns of soluble Cluster of Differentiation (sCD) antigens using high-throughput immunoassays and machine learning to generate disease-specific diagnostic signatures. The company has clinically validated its first signature for Active Tuberculosis and holds an early-stage pipeline targeting infectious, autoimmune, and inflammatory diseases, positioning it in the growing field of precision diagnostics.
View full company profile